Presentations from Southwest Prostate Cancer Symposium 2019

SESSION I: Early Detection and Staging

Screening for Prostate Cancer: PSA: Why 1.5 is the New 4.0

E. David Crawford, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

The Staggering Benefit of PSA Screening in Potentially Lethal Prostate Cancer

Patrick W. McLaughlin, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

Progress in Prostate Cancer Grading

M. Scott Lucia, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

Does the PROMIS Trial Impact Prostate Cancer Screening?

John F. Ward, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

Advanced PET Imaging for Prostate Cancer Staging

Nelson N. Stone, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

The Use of Genomic Markers and Prostate Biopsy Decisions

E. David Crawford, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

Temporal Shifts in Grade and Stage of Prostate Cancer: A Whole Mount Analysis

M. Scott Lucia, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 11, 2019, in Scottsdale, Arizona.

SESSION II: High-Risk and Advanced Prostate Cancer

Androgen Targeted Therapy Across the Continuum of Prostate Cancer

E. David Crawford, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

Role of Brachytherapy in High-Risk Prostate Cancer

Nelson N. Stone, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

Hormone Therapy in High Risk Prostate Cancer

Patrick W. McLaughlin, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

Combining SBRT and Brachytherapy in Higher Risk Prostate Cancer

Michael J. Zelefsky, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

Disease Flare with LHRH Agonists is a Myth

Abraham Morgentaler, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

External Beam Radiation Therapy for High-Risk/Locally Advanced Prostate Cancer: The Shifting Landscape

Jason A. Efstathiou, MD, Dphil, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

The Importance of a Post-Treatment Biopsy in the Management of Patients Treated with Radiotherapy for Localized Prostate Cancer

Michael J. Zelefsky, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 12, 2019, in Scottsdale, Arizona.

SESSION III: Defining Localized Disease

Pathologists Perspective on Focal Therapy

M. Scott Lucia, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

MRI-US Fusion Biopsy

Leonard S. Marks, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

Transperineal Mapping Biopsy Defines Tumor Type and Location

Nelson N. Stone, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

MRI-US Image Fusion Prostate Biopsy

John F. Ward, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

Focal Therapy of Prostate Cancer

Leonard S. Marks, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

SESSION IV: Systemic Therapy

Chemotherapy for Hormone Sensitive Metastatic Prostate Cancer

Daniel P. Petrylak, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

Testosterone Therapy in Men with Advanced Prostate Cancer

Abraham Morgentaler, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

Germline and Somatic Mutations: Can it Change Therapy?

William K. Oh, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 13, 2019, in Scottsdale, Arizona.

SESSION V: Novel Approaches to Prostate Cancer

Management of Adverse Pathology after Radical Prostatectomy

Jason A. Efstathiou, MD, DPhil, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 14, 2019, in Scottsdale, Arizona.

Role for Rectal Spacer in the Radiotherapeutic Management of Prostate Cancer

Michael J. Zelefsky, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 14, 2019, in Scottsdale, Arizona.

The Modern Definition of Successful Cancer Treatment – Cure with Quality of Life

Patrick W. McLaughlin, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 14, 2019, in Scottsdale, Arizona.

Long-Term Erectile Dysfunction and Urinary Morbidity Following Brachytherapy

Nelson N. Stone, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 14, 2019, in Scottsdale, Arizona.

Long-term Morbidity-Mortality of ADT and Radiation Therapy

Nelson N. Stone, MD, presented this lecture during the 24th Annual Southwest Prostate Cancer Symposium on April 14, 2019, in Scottsdale, Arizona.